New opportunities in cardiovascular therapies with sustained drug delivery

Today, our biomaterials experts are working closer than ever with our pharmaceutical partners to enable unique therapies that demonstrate safe and consistent outcomes for patients suffering from coronary artery disease. Our sustained drug delivery solutions allow healing to occur in applications ranging from drug-eluting stent coatings to drug coated balloons – with less frequent dosing and the potential to improve patient adherence.

We work with partners worldwide across the continuum of healthcare to enable unique cardiovascular drug delivery solutions that bring progress to life for patients

25+

Years

25+ years of experience in the cardiovascular market.

30+

Years

30+ years of experience working with the world’s leading pharmaceutical companies.

150+

Years

150+ years of combined scientific discovery and heritage as part of dsm-firmenich.

Creating next-generation therapies with TheraPEA™

Our TheraPEA™ polyester amide platform is unlocking entirely new therapeutic opportunities for the pharmaceutical industry through its ability to achieve multi-month, controlled drug release.

This highly tunable biomaterial has a zero-order degradation profile and good correlation in-vitro and in-vivo up to 180 days. Furthermore, the unique chemistry of TheraPEA™ changes the game even further through its compatibility with a wide range of challenging Active Pharmaceutical Ingredients.

By developing customized drug delivery solutions with our partners in this way, we can enable longer duration therapies for patients with the potential to increase therapy adherence – and allow for improved clinical outcomes, better healthcare economics and significantly less medical waste.

Learn more about our drug delivery solutions.

Discover our drug delivery solutions for cardiovascular applications

Our TheraPEA™ polyester amide platform provides the toughness and mechanical integrity needed for direct stenting applications - combined with enzyme mediated surface-resorption. Furthermore, its unique biodegradation mechanism eliminates the risk of acidic microenvironment, and promotes the vascular healing process.

Our polymer coating is fully absorbed by the body over time, and unlike other legacy technologies, the inherent chemical structure of TheraPEA™ makes it compatible with specific drug molecules – enabling controlled and sustained release over time.

Our biomaterial solutions for cardiovascular applications

Our biomaterials expertise in the cardiovascular market extends to a range of applications, including structural heart, vascular closure, interventional cardiology, and cardiac assist devices.